Clinical Investigation Shows Herb-Pharma's ViroStop Spray Effective in Reducing Impact of Covid-19
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
Dr István Jankovics, whose team ran the study commented, "The primary treatment for Covid 19 is, of course, vaccination, however this study means that the use of the ViroStop spray significantly inhibits the amount of SARS CoV-2 in the upper respiratory tract, thus providing an opportunity for the infected person to develop a specific immune response."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
ZURICH -- Businesswire -- A recent clinical study has shown that the ViroStop anti-viral spray from Swiss company, Herb-Pharma is effective in reducing the impact of Covid-19 for patients with mild to moderate symptoms.
The key benefits were a 60% reduction in viral shedding after using the treatment and a reduction in the severity of clinical respiratory symptoms. The study supports the findings of earlier in-vitro tests where its mix of polyphenols inhibited the growth of the virus in cell cultures.
The study included 170 PCR confirmed SARS-CoV-2 patients at the Complex Medical Clinic in Budapest, Hungary between January 15th, and May 31st, 2021. The volunteers all had mild to moderate respiratory symptoms, having tested positive in PCR tests for Covid-19 at the start of the study, and their symptoms were monitored over 12 days.
Of the 170 volunteers, 86 received a nasopharyngeal spray, the patented ViroStop solution, which contains a mixture of Cistus Creticus and other polyphenol-rich ingredients. Polyphenols when attached to viral protein, mechanically inhibit the workings of the protein, and thus stop the virus from entering the cell. The rest of the 84 patients remained in the control group and were not given the ViroStop solution. Each patient’s symptoms were checked every two days for 12 days.
At the end of the study the level of viral shedding was checked by PCR tests. Those patients who had used the ViroStop spray from the first day after testing positive, showed an almost 60% reduction in viral shedding on day 12, compared to the control group. The study showed that the severity of respiratory clinical symptoms was also reduced in those who used ViroStop spray.
A reduction was also noted in gastrointestinal symptoms compared to the control group. Recent research has shown that a key factor in the spread of the virus is its ability to also multiply in the gastrointestinal tract.
Dr István Jankovics, whose team ran the study commented, “The primary treatment for Covid 19 is, of course, vaccination, however this study means that the use of the ViroStop spray significantly inhibits the amount of SARS CoV-2 in the upper respiratory tract, thus providing an opportunity for the infected person to develop a specific immune response.”
ViroStop is a non-prescription treatment, made from natural ingredients and can be taken safely by children as young as three. Furthermore, at the time of the study, at least three variants of the virus were present in Hungary, so it is reasonable to assume that the solution and the action of polyphenols is effective against all known mutations of Covid-19.
Issued on behalf of:
Herb-Pharma AG Waldmannstrasse 6, 8001 Zurich, Switzerland
Company email: home@herb-pharma.com For more information visit: https://www.virostop.info/ Company website: https://www.fytofontana.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005309/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Herb-Pharma
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- NHN KCP, 경기도형 오픈이노베이션 사업 참여… 스타트업과 성장 동력 모색 - 뉴스와이어
- 투썸플레이스, 비비×투썸 ‘달디단 밤양갱’ 음료 여름 한정 론칭 - 뉴스와이어
- 엔비피헬스케어, 특허청 ‘지식 재산 경영 인증’ 획득… 국내외 특허등록 95건 돌파 - 뉴스와이
- 다시 깨어난 3500억 숙취해소제 시장… 스틱형 성장세 주목 - 뉴스와이어
- 현대자동차, ST1 카고 및 카고 냉동 출시 - 뉴스와이어
- 대웅제약 펙수클루, 1분기 처방액 57% 성장… 3세대 위장약 P-CAB 성장 이끌어 - 뉴스와이어
- 롯데건설 ‘계양 롯데캐슬 파크시티’ 26일 견본주택 오픈 - 뉴스와이어
- 한글 문화상품의 매력을 세계에 알린다 - 뉴스와이어
- 비즈니스북스 ‘1천만 원으로 시작하는 수도권 아파트 투자의 기적’ 출간 - 뉴스와이어
- 죽향 이생강 명인 ‘구전심수 82년 젓대소리’ 공연 열어 - 뉴스와이어